Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019771 · ClinicalTrials.gov registry record
Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 150
- Enrollment target
NCT02019771: Completed study, sponsored by University of Nebraska.
NCT02019771 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019771 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study will estimate the rates of asymptomatic Chlamydia and/or Gonorrhea in the oropharynx, rectum and urethra (urine) of HIV infected men who have sex with men at a specialty care center and compare it to the rates in Douglas County, using nucleic acid amplification tests.
Primary Outcome
Investigators will use nucleic acid amplification tests in urine, rectal and oropharyngeal swab specimens to detect asymptomatic chlamydia and/or gonorrhea infection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-03-07 |
| Est. Completion | 2014-10-01 |
What the finished NCT02019771 record still lists
NCT02019771 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02019771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019771 about?
NCT02019771 is a clinical study titled "Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men". This study will estimate the rates of asymptomatic Chlamydia and/or Gonorrhea in the oropharynx, rectum and urethra (urine) of HIV infected men who have sex with men at a specialty care center and compare it to the rates in Douglas County, using nucleic acid amplification tests.
What is the current status of trial NCT02019771?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-03-07. Estimated completion is 2014-10-01.
Who is sponsoring clinical trial NCT02019771?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI